androstenedione has been researched along with dactolisib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bane, FT; Bleach, R; Creevey, L; Hill, AD; Madden, SF; McIlroy, M; Toomey, S; Varešlija, D; Young, LS | 1 |
1 other study(ies) available for androstenedione and dactolisib
Article | Year |
---|---|
Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy.
Topics: Adaptation, Physiological; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Survival; Disease-Free Survival; Drug Resistance, Neoplasm; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Postmenopause; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Quinolines; Receptors, Androgen; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Steroids; Transcriptome; Up-Regulation | 2019 |